[2014 classification of lung carcinomas: latest entities and clinical implications. Case 2: Basaloid carcinoma].
Service de pathologie, hôpital central, 29, avenue du Maréchal-de-Lattre-de-Tassigny, 54035 Nancy cedex, France. Electronic address: jm.vignaud@chu-nancy.fr.
Jean-Michel
JM
Vignaud
D014408:Biomarkers, Tumor / Q000032:analysis; D018287:Carcinoma, Large Cell / Q000737:chemistry / Q000145:classification / Q000175:diagnosis / Q000473:pathology*; D002294:Carcinoma, Squamous Cell / Q000601:surgery; D002454:Cell Differentiation; D003937:Diagnosis, Differential; D006801:Humans; D007124:Immunoenzyme Techniques; D053531:Keratins, Type II / Q000032:analysis; D008175:Lung Neoplasms / Q000737:chemistry / Q000145:classification / Q000175:diagnosis / Q000473:pathology*; D008297:Male; D008565:Membrane Proteins / Q000032:analysis; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000737:chemistry / Q000145:classification / Q000175:diagnosis / Q000473:pathology*; D018358:Neuroendocrine Tumors / Q000175:diagnosis; D010039:Otorhinolaryngologic Neoplasms / Q000601:surgery; D011379:Prognosis
D014408:Biomarkers, Tumor; C081876:CKAP4 protein, human; D053531:Keratins, Type II; D008565:Membrane Proteins